C10orf32 (BLOC-1 related complex subunit 7) is a component of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), which plays a role in the trafficking and sorting of proteins to lysosome-related organelles. Certain chemicals have been identified that can enhance the functional activity of C10orf32 through diverse mechanisms that converge on the modulation of intracellular signaling molecules. These activators primarily work through the elevation of intracellular cyclic AMP (cAMP), which serves as a secondary messenger in various signaling pathways. Enhanced levels of cAMP typically activate protein kinase A (PKA), a key regulator of numerous cellular processes. The activation of PKA can lead to the phosphorylation of target proteins, which may include C10orf32, thereby modulating its functional activity within the cell.
The upstream stimulation of cAMP levels can occur through several mechanisms, including the activation of G-protein coupled receptors, inhibition of phosphodiesterases, or adrenergic receptor stimulation. Chemicals that function as beta-adrenergic agonists or inhibitors of specific phosphodiesterase isoforms can lead to an increase in cAMP, which in turn activates PKA. The subsequent PKA-mediated phosphorylation may influence the activity of C10orf32, thereby potentially enhancing its role within the BLOC-1 complex. In addition to these mechanisms, other compounds can indirectly affect cAMP levels by modulating related signaling molecules like cGMP.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP and cGMP by preventing their degradation, potentially enhancing PKA activity and leading to the phosphorylation of C10orf32. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Stimulates adrenergic receptors, leading to increased cAMP production, which could activate PKA and promote the phosphorylation of C10orf32. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist that increases cAMP levels, which may lead to the activation of PKA and the subsequent phosphorylation and activation of C10orf32. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Activates G-protein coupled receptors, which increases cAMP levels, potentially leading to PKA activation and phosphorylation of C10orf32. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Phosphodiesterase-4 inhibitor, increases cAMP levels, which may lead to PKA activation and subsequent phosphorylation of C10orf32. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
Phosphodiesterase-3 inhibitor, raises cAMP levels, potentially leading to PKA activation and phosphorylation of C10orf32. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Inhibitor of phosphodiesterase-5, elevates cGMP levels, which might indirectly influence cAMP levels and lead to PKA-mediated phosphorylation of C10orf32. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $147.00 | ||
Inhibits phosphodiesterase-3, increases cAMP levels, which may lead to PKA activation and phosphorylation of C10orf32. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Beta-adrenergic agonist, increases cAMP production, potentially leading to PKA activation and phosphorylation of C10orf32. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $162.00 $683.00 | 7 | |
Selective phosphodiesterase-3 inhibitor, increases cAMP levels, which could lead to PKA activation and phosphorylation of C10orf32. | ||||||